Childhood granulomatous periorificial dermatitis: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Childhood granulomatous periorificial dermatitis | |||
| synonyms = Facial Afro-Caribbean childhood eruption (FACE) | |||
| field = [[Dermatology]] | |||
| symptoms = Papular rash around the [[mouth]], [[nose]], and [[eyes]] | |||
| complications = Possible [[scarring]] | |||
| onset = [[Childhood]] | |||
| duration = [[Chronic (medicine)|Chronic]] | |||
| causes = Unknown | |||
| risks = More common in [[Afro-Caribbean]] children | |||
| diagnosis = [[Clinical diagnosis|Clinical]] | |||
| differential = [[Perioral dermatitis]], [[Sarcoidosis]], [[Granulomatous rosacea]] | |||
| treatment = [[Topical antibiotics]], [[Topical corticosteroids]] | |||
| medication = [[Metronidazole]], [[Erythromycin]] | |||
| frequency = Rare | |||
}} | |||
{{Short description|A rare skin condition affecting children}} | {{Short description|A rare skin condition affecting children}} | ||
'''Childhood granulomatous periorificial dermatitis''' (CGPD) is a rare dermatological condition that primarily affects children. It is characterized by the presence of papular eruptions around the orifices of the face, such as the mouth, nose, and eyes. This condition is also known as facial Afro-Caribbean childhood eruption (FACE) due to its higher prevalence in children of African descent. | '''Childhood granulomatous periorificial dermatitis''' (CGPD) is a rare dermatological condition that primarily affects children. It is characterized by the presence of papular eruptions around the orifices of the face, such as the mouth, nose, and eyes. This condition is also known as facial Afro-Caribbean childhood eruption (FACE) due to its higher prevalence in children of African descent. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
CGPD typically presents as small, flesh-colored to erythematous papules that are symmetrically distributed around the periorificial areas of the face. These papules may coalesce to form plaques. The condition is usually asymptomatic, although some patients may experience mild itching or burning sensations. | CGPD typically presents as small, flesh-colored to erythematous papules that are symmetrically distributed around the periorificial areas of the face. These papules may coalesce to form plaques. The condition is usually asymptomatic, although some patients may experience mild itching or burning sensations. | ||
==Etiology== | ==Etiology== | ||
The exact cause of CGPD is unknown. However, it is believed to be a variant of [[perioral dermatitis]], with potential contributing factors including the use of topical corticosteroids, exposure to certain environmental factors, and genetic predisposition. The condition is more commonly observed in children with darker skin types. | The exact cause of CGPD is unknown. However, it is believed to be a variant of [[perioral dermatitis]], with potential contributing factors including the use of topical corticosteroids, exposure to certain environmental factors, and genetic predisposition. The condition is more commonly observed in children with darker skin types. | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of CGPD is primarily clinical, based on the characteristic appearance and distribution of the lesions. A skin biopsy may be performed to confirm the diagnosis, revealing granulomatous inflammation in the dermis. Differential diagnoses include [[sarcoidosis]], [[lupus miliaris disseminatus faciei]], and [[granulomatous rosacea]]. | The diagnosis of CGPD is primarily clinical, based on the characteristic appearance and distribution of the lesions. A skin biopsy may be performed to confirm the diagnosis, revealing granulomatous inflammation in the dermis. Differential diagnoses include [[sarcoidosis]], [[lupus miliaris disseminatus faciei]], and [[granulomatous rosacea]]. | ||
==Management== | ==Management== | ||
Treatment of CGPD involves the discontinuation of any topical corticosteroids and the use of topical or oral antibiotics, such as metronidazole or erythromycin. In some cases, topical calcineurin inhibitors like tacrolimus may be effective. The condition often resolves spontaneously over time, but treatment can help accelerate the resolution of lesions. | Treatment of CGPD involves the discontinuation of any topical corticosteroids and the use of topical or oral antibiotics, such as metronidazole or erythromycin. In some cases, topical calcineurin inhibitors like tacrolimus may be effective. The condition often resolves spontaneously over time, but treatment can help accelerate the resolution of lesions. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for CGPD is generally good, with most cases resolving without significant scarring or complications. However, the condition may persist for several months to years before complete resolution. | The prognosis for CGPD is generally good, with most cases resolving without significant scarring or complications. However, the condition may persist for several months to years before complete resolution. | ||
==Related Pages== | ==Related Pages== | ||
* [[Perioral dermatitis]] | * [[Perioral dermatitis]] | ||
* [[Granulomatous diseases]] | * [[Granulomatous diseases]] | ||
* [[Dermatology]] | * [[Dermatology]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Skin conditions in children]] | [[Category:Skin conditions in children]] | ||
Latest revision as of 22:55, 3 April 2025
| Childhood granulomatous periorificial dermatitis | |
|---|---|
| Synonyms | Facial Afro-Caribbean childhood eruption (FACE) |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Papular rash around the mouth, nose, and eyes |
| Complications | Possible scarring |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | More common in Afro-Caribbean children |
| Diagnosis | Clinical |
| Differential diagnosis | Perioral dermatitis, Sarcoidosis, Granulomatous rosacea |
| Prevention | N/A |
| Treatment | Topical antibiotics, Topical corticosteroids |
| Medication | Metronidazole, Erythromycin |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Childhood granulomatous periorificial dermatitis (CGPD) is a rare dermatological condition that primarily affects children. It is characterized by the presence of papular eruptions around the orifices of the face, such as the mouth, nose, and eyes. This condition is also known as facial Afro-Caribbean childhood eruption (FACE) due to its higher prevalence in children of African descent.
Clinical Presentation[edit]
CGPD typically presents as small, flesh-colored to erythematous papules that are symmetrically distributed around the periorificial areas of the face. These papules may coalesce to form plaques. The condition is usually asymptomatic, although some patients may experience mild itching or burning sensations.
Etiology[edit]
The exact cause of CGPD is unknown. However, it is believed to be a variant of perioral dermatitis, with potential contributing factors including the use of topical corticosteroids, exposure to certain environmental factors, and genetic predisposition. The condition is more commonly observed in children with darker skin types.
Diagnosis[edit]
The diagnosis of CGPD is primarily clinical, based on the characteristic appearance and distribution of the lesions. A skin biopsy may be performed to confirm the diagnosis, revealing granulomatous inflammation in the dermis. Differential diagnoses include sarcoidosis, lupus miliaris disseminatus faciei, and granulomatous rosacea.
Management[edit]
Treatment of CGPD involves the discontinuation of any topical corticosteroids and the use of topical or oral antibiotics, such as metronidazole or erythromycin. In some cases, topical calcineurin inhibitors like tacrolimus may be effective. The condition often resolves spontaneously over time, but treatment can help accelerate the resolution of lesions.
Prognosis[edit]
The prognosis for CGPD is generally good, with most cases resolving without significant scarring or complications. However, the condition may persist for several months to years before complete resolution.
